title: Activation of the c-H-ras proto-oncogene by retrovirus insertion and chromosomal rearrangement in a Moloney leukemia virus-induced T-cell leukemia.
abstract: A rearrangement of the c-H-ras locus was detected in a T-cell line (DA-2) established from a Moloney leukemia virus-induced tumor. This rearrangement was associated with the high-level expression of H-ras RNA and the H-ras gene product, p21. DNA from DA-2 cells transformed fibroblasts in DNA transfection experiments, and the transformed fibroblasts contained the rearranged H-ras locus. The rearrangement involved one allele and was present in tissue from the primary tumor from which the cell line was isolated. Cloning and sequencing of the rearranged allele and comparison with the normal allele demonstrated that the rearrangement was complex and probably resulted from the integration of a retrovirus in the H-ras locus between a 5' noncoding exon and the first coding exon and a subsequent homologous recombination between this provirus and another newly acquired provirus also located on chromosome 7. These events resulted in the translocation of the coding exons of the H-ras locus away from the 5' noncoding exon region to a new genomic site on chromosome 7. Sequencing of the coding regions of the gene failed to detect mutations in the 12th, 13th, 59th, or 61st codons. The possible reasons for the complexity of the rearrangement and the significance of the activation of the H-ras locus to T-cell transformation are discussed.
authors.affiliation: Molecular Mechanisms of Carcinogenesis Laboratory, National Cancer Institute-Frederick, Cancer Research Facility, Maryland 21701.
authors.forename: J N
authors.initials: JN
authors.lastname: Ihle
authors.forename: B
authors.initials: B
authors.lastname: Smith-White
authors.forename: B
authors.initials: B
authors.lastname: Sisson
authors.forename: D
authors.initials: D
authors.lastname: Parker
authors.forename: D G
authors.initials: DG
authors.lastname: Blair
authors.forename: A
authors.initials: A
authors.lastname: Schultz
authors.forename: C
authors.initials: C
authors.lastname: Kozak
authors.forename: R D
authors.initials: RD
authors.lastname: Lunsford
authors.forename: D
authors.initials: D
authors.lastname: Askew
authors.forename: Y
authors.initials: Y
authors.lastname: Weinstein
mesh_terms: D000483:Alleles; D000818:Animals; D001483:Base Sequence; D002460:Cell Line; D002471:Cell Transformation, Neoplastic; D003001:Cloning, Molecular; D004251:DNA Transposable Elements; D005786:Gene Expression Regulation; D015321:Gene Rearrangement; D011905:Genes, ras; D006801:Humans; D015151:Immunoblotting; D007942:Leukemia, Experimental / Q000235:genetics* / Q000382:microbiology; D015458:Leukemia, T-Cell / Q000235:genetics* / Q000382:microbiology; D008565:Membrane Proteins / Q000235:genetics*; D051379:Mice; D008969:Molecular Sequence Data; D008979:Moloney murine leukemia virus / Q000235:genetics*; D009693:Nucleic Acid Hybridization; D000090063:Proto-Oncogene Mas; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D016283:Proto-Oncogene Proteins p21(ras); D012367:RNA, Viral / Q000235:genetics; D015183:Restriction Mapping; D014162:Transfection
chemical_list: D004251:DNA Transposable Elements; C000715470:MAS1 protein, human; D008565:Membrane Proteins; D000090063:Proto-Oncogene Mas; D011518:Proto-Oncogene Proteins; D012367:RNA, Viral; C501009:HRAS protein, human; D016283:Proto-Oncogene Proteins p21(ras)